"Leica" Bond Ready-to-Use Primary Antibody Kappa Light Chain (CH15) (Non-Sterile) - Taiwan Registration fe7e523cfc51e11ab1927f786c23b03d
Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Kappa Light Chain (CH15) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number fe7e523cfc51e11ab1927f786c23b03d and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
fe7e523cfc51e11ab1927f786c23b03d
Ministry of Health Medical Device Import No. 019544
DHA09401954402
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology and pathology devices
B1860 Immunopathological histochemical reagents and kits
Imported from abroad
Dates and Status
Aug 28, 2018
Aug 28, 2028

